Key facts
- UK scientists are trialling a new vaccine technology.
- The technology does not require refrigeration.
- Inspiration for the technology comes from resurrection plants.
- The innovation aims to reduce vaccine wastage.
- Wastage is often caused by cold chain failures.
- The technology could improve global access to immunisation.
Scientists in the United Kingdom have advanced a new vaccine technology that eliminates the need for refrigeration, a development inspired by the resilience of resurrection plants. This innovative approach is designed to address the considerable wastage of vaccines that arises from disruptions in the cold chain, a critical factor in maintaining vaccine efficacy. By removing the reliance on constant refrigeration, this technology could dramatically improve the accessibility of immunisations worldwide. The current cold chain infrastructure presents significant logistical challenges and costs, particularly in regions with limited access to reliable electricity and advanced storage facilities. Vaccine spoilage due to temperature fluctuations is a major contributor to global health disparities, leading to a loss of valuable resources and hindering effective disease prevention campaigns. This fridge-free technology offers a potential solution to these persistent problems, promising more stable and equitable distribution of vital vaccines. The inspiration drawn from resurrection plants, which can survive extreme dehydration and rehydrate to a living state, highlights a natural mechanism for preserving biological materials without constant temperature control. Further development and trials are expected to assess the long-term stability, efficacy, and scalability of this promising new vaccine delivery system.